Human immunodeficiency virus neutralizing antibodies
AssigneeGilead Sciences, Inc.
InventorsMini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
Life of this patent
Estimating the term…
Abstract
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Claims71
An antibody or an antigen-binding fragment thereof that binds to human immunodeficiency virus-1 (HIV-1) Envelope glycoprotein gp120, the antibody or antigen-binding fragment thereof comprising heavy chain variable region complementary determining regions 1-3 (CDRs 1-3) set forth in SEQ ID NOs:362, 366 and 367, respectively, and light chain variable region CDRs 1-3 set forth in SEQ ID NOs:395, 396 and 397, respectively.
An antibody or an antigen-binding fragment thereof, the antibody or antigen-binding fragment thereof comprising a heavy chain variable region and a light chain variable region, wherein:
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:211 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:297;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:213 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:299;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:227 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:313;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:248 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:334;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:249 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:335;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:250 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:336;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:251 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:337;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:252 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:338;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:255 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:341;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:262 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:348;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:263 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:349;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:264 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:350;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:265 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:351;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:266 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:352;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:267 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:353;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:272 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:358;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:273 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:359;
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:274 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:360;
- or
- the heavy chain variable region comprises the amino acid sequence set forth in amino acids 1-132 of SEQ ID NO:275 and the light chain variable region comprises the amino acid sequence set forth in amino acids 1-105 of SEQ ID NO:361.
Dependencies are inferred from the claim text.